Tag: 6-TGN
Azathioprine and Allopurinol: How Low-Dose Combination Therapy Prevents Toxic Metabolite Buildup
LDAA therapy combines low-dose azathioprine with allopurinol to redirect toxic metabolite production, improving efficacy and reducing liver damage in IBD and autoimmune hepatitis patients with high TPMT activity.
Read More
0 Comments